CTLA4 and melanoma: In a murine model of melanoma, the combination of chemotherapy and CTLA-4 blockade induced a cellular shift in the local tumor microenvironment, with infiltrating CD8 + and CD4 + T cells increasing the CD8 + /Foxp3 T-cell ratio and leading to an improved survival [49].